Showing 1,121 - 1,140 results of 25,884 for search '(( significant decrease decrease ) OR ( significant ((advances decrease) OR (advanced disease)) ))*', query time: 0.59s Refine Results
  1. 1121

    Analysis of TO dynamics (post epidemic). by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  2. 1122

    Static spillover effects in stage 3 (post epidemic). by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  3. 1123
  4. 1124

    Dynamics of pairwise net spillovers between sectors in the first stage (pre-epidemic). by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  5. 1125

    Changes in total spillage during the first stage (pre-epidemic). by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  6. 1126

    Changes in total spillage during the third stage (post epidemic). by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  7. 1127

    Dynamics of pairwise net spillovers between sectors in the second stage (in- epidemic). by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  8. 1128

    Sample stage division. by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  9. 1129

    First. by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  10. 1130

    Static spillovers in the first stage (pre-epidemic). by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  11. 1131

    Changes in total spillage during the second stage (in-epidemic). by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  12. 1132

    Dynamics of net spillage in the second stage (in-epidemic). by Cuicui Liu (1496260)

    Published 2024
    Subjects: “…phenomenon intensified significantly…”
  13. 1133
  14. 1134
  15. 1135
  16. 1136

    Table 1_Efficacy and safety of cadonilimab combined with AG chemotherapy in patients with unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma: a retrospect... by Wenke Qin (20390989)

    Published 2025
    “…Among patients with a decrease in CA19-9, the median overall survival was significantly prolonged (12.92 vs 8.89 months, P = 0.027); patients with a platelet-lymphocyte ratio (PLR) ≤ 165.62 had a significantly better mOS (12.37 vs 8.74 months, P = 0.025). …”
  17. 1137
  18. 1138
  19. 1139
  20. 1140